Ching-Yi Lin
Recent Quotes
"STEM has included stricter patient criteria in its Phase 2 dry AMD trial."
—
Ching-Yi Lin, H.C. Wainwright & Co.
(8/7/15)
more >
Due to permission requirements, not all quotes are shown.